Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:29 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 364 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Acute Coronary Syndrome Clear all

Conditions: Acute Coronary Syndrome
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 40 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chest Pain, Acute Coronary Syndrome, Pulmonary Embolism, Aortic Dissection
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: 30 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Acute Coronary Syndrome
Interventions: Triage CardioProfilER (Troponin I, Myoglobin, CK-MB, BNP); Device
Lead sponsor: Abbott RDx Cardiometabolic; Other
Eligibility: 21 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 6
States / cities: Sacramento, California • Detroit, Michigan • Charlotte, North Carolina + 3 more

Conditions: Acute Coronary Syndrome
Interventions: Not listed
Lead sponsor: Trinity Biotech; Industry
Eligibility: 21 Years and older
Enrollment: 769 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania • Charleston, South Carolina • Layton, Utah

Conditions: Acute Coronary Syndrome, Multi Vessel Coronary Artery Disease, Ischemic Stroke
Interventions: Life and Medication Recommendations; Behavioral
Lead sponsor: LifeBridge Health; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Atherosclerosis
Interventions: Not listed
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 476 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 3
States / cities: Miami, Florida • Bethesda, Maryland • Royal Oak, Michigan

Conditions: Infection, Hypervolemia, Hypovolemia, Septic Shock, Acute Heart Failure, Congestive Heart Failure
Interventions: Peripheral Intravenous Analysis (PIVA), Non-invasive fluid response measure, Passive leg raise (PLR); Procedure · Diagnostic Test
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 3
States / cities: Boston, Massachusetts • Worcester, Massachusetts • Seattle, Washington

Conditions: Heart Failure, Obstructive Sleep Apnea, Heart Failure, Congestive
Interventions: CPAP Therapy; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older
Enrollment: 154 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Acute Coronary Syndrome
Interventions: Ticagrelor + ASA + Bivalirudin, Clopidogrel + ASA + Bivalirudin; Drug
Lead sponsor: Juan J Badimon; Other
Eligibility: 18 Years to 65 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease, Percutaneous Coronary Intervention
Interventions: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin, Plavix (clopidogrel 75 mg) and aspirin; Drug
Lead sponsor: Cogentus Pharmaceuticals; Industry
Eligibility: 21 Years and older
Enrollment: 5,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 247
States / cities: Alexander City, Alabama • Birmingham, Alabama • Geneva, Alabama + 205 more

Conditions: ACS - Acute Coronary Syndrome
Interventions: Positive Psychology + Motivational Interviewing, Motivational Interviewing Health Education; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Coronary Artery Disease, Acute Coronary Syndrome
Interventions: Ticagrelor 180mg, Prasugrel 10mg, Ticagrelor 90mg; Drug
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 74 Years
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Lung Neoplasms, Respiratory Failure, Pneumonia, Acute Coronary Syndromes, Unstable Angina, Myocardial Infarction, Cardiac Arrhythmia, Thromboembolic Disease
Interventions: Normal Saline, Sodium Bicarbonate; Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Acute Coronary Syndrome
Interventions: Not listed
Lead sponsor: Chattanooga-Hamilton County Hospital Authority; Other
Eligibility: 18 Years and older
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Chattanooga, Tennessee

Conditions: Acute Coronary Syndromes
Interventions: CER-001, Placebo; Drug
Lead sponsor: Cerenis Therapeutics, SA; Industry
Eligibility: 18 Years and older
Enrollment: 301 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 13
States / cities: Huntsville, Alabama • San Diego, California • Torrance, California + 9 more

Conditions: Acute Coronary Syndrome, Sleep Disorder
Interventions: Eszopiclone, Placebo; Drug · Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Blood Platelets
Interventions: rosuvastatin, placebo; Drug
Lead sponsor: Susan Smyth; Other
Eligibility: 18 Years to 80 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Postural Tachycardia Syndrome, Orthostatic Tachycardia, Orthostatic Intolerance
Interventions: normal saline (0.9%); Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Coronary Arteriosclerosis, Non ST Segment Elevation Acute Coronary Syndrome
Interventions: OrbusNeich Combo stent™, Everolimus Eluting Stent (EES); Device
Lead sponsor: OrbusNeich; Industry
Eligibility: 20 Years and older
Enrollment: 572 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2021
U.S. locations: 17
States / cities: Washington D.C., District of Columbia • Lake Worth, Florida • Miami, Florida + 14 more

Conditions: Stable Angina (SA), Unstable Angina (UA), NSTEMI - Non-ST Segment Elevation MI
Interventions: Non-Fasting, Fasting; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Angina, Unstable, Cardiovascular Diseases, Heart Diseases, Coronary Disease, Myocardial Infarction, Heart Failure, Congestive
Interventions: GIK, Placebo; Drug
Lead sponsor: Tufts Medical Center; Other
Eligibility: 30 Years and older
Enrollment: 911 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 13
States / cities: Anchorage, Alaska • New Haven, Connecticut • Macon, Georgia + 10 more

Conditions: Complex Aortic Aneurysms, Thoracoabdominal Aneurysms, Pararenal Aneurysms, Juxtarenal Aneurysms, Marfan Syndrome, Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Aortic Arch Aneurysm
Interventions: Custom Made Fenestrated or Branched Stent Graft; Device
Lead sponsor: Andres Schanzer; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2030
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Acute Coronary Syndrome
Interventions: 4th Gen cTnT, 5th Gen cTnT; Diagnostic Test
Lead sponsor: Columbia University; Other
Eligibility: 19 Years and older
Enrollment: 1,949 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Coronary Syndrome, Depression
Interventions: Problem Solving Therapy, Sertraline, citalopram, or bupropion, Standard care; Behavioral · Drug · Other
Lead sponsor: Columbia University; Other
Eligibility: 35 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 5
States / cities: New Haven, Connecticut • Atlanta, Georgia • St Louis, Missouri + 2 more

Search by objective public record fields.

Stress-Delta Biomarkers for Acute Coronary Syndrome Risk Stratification

Diagnostic Accuracy of Multislice CT Angiography for Acute Chest Pain

Rapid Assessment of Cardiac Markers for the Evaluation of Acute Coronary Syndrome (RACE-ACS)

99th Percentile Upper Reference Limit (URL) for the Meritas Troponin I Test

Multidisciplinary Approach to Reduce Cardiovascular Health Disparities

Incident COronary EveNts Identified by Computed Tomography

Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients

The Role of Sleep Apnea in the Acute Exacerbation of Heart Failure

Antithrombotic Effects of Ticagrelor Versus Clopidogrel

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Positive Psychology for Acute Coronary Syndrome Patients

Pharmacodynamic Evaluation of Switching From Prasugrel to Ticagrelor

Clearance Of Mucus In Stents (COMIS)

Usefulness of a 2-hour Delta Troponin-I During the ED Identification and Exclusion of Acute Myocardial Infarction

CER-001 Atherosclerosis Regression ACS Trial

Eszopiclone and Inflammatory Mediators in Patients With Acute Coronary Syndrome

Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions

Acute Salt Handling in Orthostatic Intolerance

HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

Breaking Fasts Ahead of Cardiac Caths

IMMEDIATE Trial - Out of Hospital Administration of Glucose, Insulin and Potassium.

Complex Aortic Aneurysm Repair Using Physician Modified Endografts and Custom Made Devices

5th Generation cTnT in ED ACS

Comparison of Depression Interventions After Acute Coronary Syndrome